0000921895-20-000902.txt : 20200324 0000921895-20-000902.hdr.sgml : 20200324 20200324205052 ACCESSION NUMBER: 0000921895-20-000902 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200320 FILED AS OF DATE: 20200324 DATE AS OF CHANGE: 20200324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deliargyris Efthymios CENTRAL INDEX KEY: 0001751617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36351 FILM NUMBER: 20739792 MAIL ADDRESS: STREET 1: C/O PLX PHARMA,INC.8285 EL RIO STREET STREET 2: SUITE 210 CITY: HOUSTON STATE: TX ZIP: 77054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLx Pharma Inc. CENTRAL INDEX KEY: 0001497504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271707962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 FISHERS LANE STREET 2: SUITE E CITY: SPARTA STATE: NJ ZIP: 07871 BUSINESS PHONE: (713) 842-1249 MAIL ADDRESS: STREET 1: 9 FISHERS LANE STREET 2: SUITE E CITY: SPARTA STATE: NJ ZIP: 07871 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140313 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC DATE OF NAME CHANGE: 20100726 4 1 form411577002del_03242020.xml OWNERSHIP DOCUMENT X0306 4 2020-03-20 0 0001497504 PLx Pharma Inc. PLXP 0001751617 Deliargyris Efthymios 9 FISHERS LANE SUITE E SPARTA NJ 07871 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 2.16 2020-03-20 4 A 0 60000 0 A 2030-03-20 Common Stock 60000 60000 D Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan. These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date. /s/ Efthymios Deliargyris 2020-03-24